Pearl Steinzor

The American College of Gastroenterology (ACG) is urging the US Supreme Court to uphold the authority of the US Preventive Services Task Force (USPSTF), warning that millions of Americans could lose access to essential colorectal cancer (CRC) screenings.1 In an […]

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US, but it doesn’t have to be.1 With early detection and proactive lifestyle choices, many cases are preventable or treatable. However, cases are rising among younger adults,

Today, the US Senate Committee on Health, Education, Labor and Pensions (HELP) hearing on President Donald Trump’s nominee to lead the National Institutes of Health (NIH), Jay Bhattacharya, MD, PhD, included debate over research funding priorities, transparency, and lessons from

Today, the US Multi-Society Task Force on Colorectal Cancer (MSTFCRC) released updated guidelines for optimizing bowel preparation before colonoscopy, refining best practices from its 2014 recommendations.1 The guidelines emphasize the effectiveness of split-dose regimens, flexibility in dietary restrictions, and the

Pharmacists play a role in optimizing drug regimens, monitoring adverse effects, and managing financial toxicity through insurance appeals and patient assistance programs, says Tiffany Meng, PharmD, oncology pharmacist with UCSF Health. This transcript has been lightly edited for clarity; captions

High-dose oral multivitamins and multiminerals (OMVMs) do not reduce major cardiovascular events in patients with diabetes and a prior heart attack, according to one study.1 A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation

Insurance formularies, patient assistance programs, and financial counselors play a significant role in reducing financial toxicity and removing barriers to care for patients struggling to afford breast cancer therapy, says Tiffany Meng, PharmD, oncology pharmacist, UCSF Health. This transcript has

Clear communications and respect between clinicians and patients is key when navigating optimal breast cancer care routes, says Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist, and director for the Stanford Cancer Institute and the Stanford

It is crucial to understand how social determinants of health (SDOH) are related to health literacy, so that patients can navigate a very complex health care system, says Lidia Schapira, MD, FASCO, professor of medicine at Stanford Medicine, medical oncologist,

Cetuximab (Erbitux) plus chemotherapy showed higher progression-free survival (PFS) and overall survival (OS) for patients with metastatic colorectal cancer (mCRC), according to one study. When combined with chemotherapy, cetuximab shows promising efficacy for optimizing treatment strategies for patients with metastatic